http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102002886-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04 |
| filingDate | 2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102002886-B1 |
| titleOfInvention | 2’-fluoro-6’-methylene carbocyclic nucleosides and methods of treating viral infections |
| abstract | The present invention relates to pharmaceutical compositions comprising 2'-fluoro-6'-methylene carbocyclic nucleosides, nucleosides, and in particular to hepatitis B virus (HBV) and its secondary pathologies and conditions (cirrhosis and liver cancer) , Hepatitis C virus (HCV), herpes simplex viruses type I and II (HSV-1 and HSV-2), cytomegalovirus (CMV), varicella herpesvirus (VZV) and Epstein-Barr virus (Including, but not limited to, lamivudine and / or adefovir resistance) and other mutations of such viruses), in particular, multiple (including, but not limited to, HBV) To the use of the nucleosides in the treatment or prevention of viral infections and secondary conditions and conditions thereof. |
| priorityDate | 2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 540.